These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 12020687
21. Dietary ginsenosides improve endothelium-dependent relaxation in the thoracic aorta of hypercholesterolemic rabbit. Kang SY, Kim SH, Schini VB, Kim ND. Gen Pharmacol; 1995 May; 26(3):483-7. PubMed ID: 7789720 [Abstract] [Full Text] [Related]
22. Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay. Belz GG, Butzer R, Kober S, Mang C, Mutschler E. Clin Pharmacol Ther; 1999 Oct; 66(4):367-73. PubMed ID: 10546920 [Abstract] [Full Text] [Related]
23. Effects of chronic losartan treatment on vascular reactivity in normotensive rats. Dowell FJ, Benessiano J, Poitevin P, Levy BI, Henrion D. J Hypertens; 1997 May; 15(5):523-9. PubMed ID: 9170005 [Abstract] [Full Text] [Related]
24. Effects of indapamide on vascular reactivity in hypercholesterolemic rabbits. Del Rio M, Chulia T, Tejerina T. J Cardiovasc Pharmacol; 1993 May; 22 Suppl 6():S8-12. PubMed ID: 7508067 [Abstract] [Full Text] [Related]
25. Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan. Shetty SS, DelGrande D. J Pharmacol Exp Ther; 2000 Jul; 294(1):179-86. PubMed ID: 10871310 [Abstract] [Full Text] [Related]
26. The angiotensin AT(1) receptor antagonist irbesartan has near-peptide affinity and potently blocks receptor signaling. Hines J, Fluharty SJ, Sakai RR. Eur J Pharmacol; 1999 Nov 12; 384(1):81-9. PubMed ID: 10611423 [Abstract] [Full Text] [Related]
28. Intracavernosal injections of vascular endothelial growth factor protects endothelial dependent corpora cavernosal smooth muscle relaxation in the hypercholesterolemic rabbit: a preliminary study. Henry GD, Byrne R, Hunyh TT, Abraham V, Annex BH, Hagen PO, Donatucci CF. Int J Impot Res; 2000 Dec 12; 12(6):334-9. PubMed ID: 11416837 [Abstract] [Full Text] [Related]
29. Modulation of matrix metalloproteinase-1, its tissue inhibitor, and nuclear factor-kappa B by losartan in hypercholesterolemic rabbits. Chen H, Li D, Mehta JL. J Cardiovasc Pharmacol; 2002 Mar 12; 39(3):332-9. PubMed ID: 11862111 [Abstract] [Full Text] [Related]
30. Prevention of intimal thickening after endothelial removal by a nonpeptide angiotensin II receptor antagonist, losartan. Azuma H, Niimi Y, Hamasaki H. Br J Pharmacol; 1992 Jul 12; 106(3):665-71. PubMed ID: 1504750 [Abstract] [Full Text] [Related]
31. Effects of vitamin E on endothelium-dependent coronary flow in hypercholesterolemic dogs. Jorge PA, Osaki MR, de Almeida E, Credídio Neto L, Metze K. Atherosclerosis; 1996 Sep 27; 126(1):43-51. PubMed ID: 8879433 [Abstract] [Full Text] [Related]
32. Functional properties in vitro of systemic small arteries from rabbits fed a cholesterol-rich diet for 12 weeks. Simonsen U, Ehrnrooth E, Gerdes LU, Faergemann O, Buch J, Andreasen F, Mulvany MJ. Clin Sci (Lond); 1991 Feb 27; 80(2):119-29. PubMed ID: 1848163 [Abstract] [Full Text] [Related]
33. Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. Keaney JF, Gaziano JM, Xu A, Frei B, Curran-Celentano J, Shwaery GT, Loscalzo J, Vita JA. J Clin Invest; 1994 Feb 27; 93(2):844-51. PubMed ID: 8113416 [Abstract] [Full Text] [Related]
34. Influence of atherosclerosis on vascular responsiveness in isolated rabbit vascular smooth muscle. Lefer AM, Osborne JA, Yanagisawa A, Sun JZ. Cardiovasc Drugs Ther; 1987 Dec 27; 1(4):385-91. PubMed ID: 3155317 [Abstract] [Full Text] [Related]
35. Effect of hypercholesterolemia on vascular reactivity in the rabbit. II. Influence of treatment with dipyridamole on endothelium-dependent and endothelium-independent responses in isolated aortas of control and hypercholesterolemic rabbits. Verbeuren TJ, Coene MC, Jordaens FH, Van Hove CE, Zonnekeyn LL, Herman AG. Circ Res; 1986 Nov 27; 59(5):496-504. PubMed ID: 3802425 [Abstract] [Full Text] [Related]
36. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation. Luchtefeld M, Bandlow N, Tietge UJ, Grote K, Pfeilschifter J, Kaszkin M, Beck S, Drexler H, Schieffer B. Atherosclerosis; 2007 Sep 27; 194(1):62-70. PubMed ID: 17069818 [Abstract] [Full Text] [Related]
37. Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats. Failli P, Alfarano C, Franchi-Micheli S, Mannucci E, Cerbai E, Mugelli A, Raimondi L. Cardiovasc Diabetol; 2009 Jun 22; 8():32. PubMed ID: 19545435 [Abstract] [Full Text] [Related]
38. Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing. Maillard MP, Würzner G, Nussberger J, Centeno C, Burnier M, Brunner HR. Clin Pharmacol Ther; 2002 Jan 22; 71(1):68-76. PubMed ID: 11823759 [Abstract] [Full Text] [Related]
39. Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding. Fierens FL, Vanderheyden PM, De Backer JP, Vauquelin G. Eur J Pharmacol; 1999 May 14; 372(2):199-206. PubMed ID: 10395100 [Abstract] [Full Text] [Related]
40. Improvement in the endothelium-dependent relaxation in hypercholesterolemic rabbits treated with vitamin E. Ribeiro Jorge PA, Neyra LC, Ozaki RM, de Almeida E. Atherosclerosis; 1998 Oct 14; 140(2):333-9. PubMed ID: 9862276 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]